Technology stocks declined comprehensively on Wall Street, with the segment seeing a general decay of 0.3%.
Transgenomic, Inc. (TBIO) reported that it plans to offer shares of the organization’s normal stock and relating warrants to buy shares of the organization’s regular stock in a guaranteed open advertising. Craig-Hallum Capital Group LLC is going about as the sole overseeing guarantor of the advertising.
Transgenomic, Inc. (TBIO) proclaimed the evaluating of a guaranteed open offering of 3,573,899 shares of the organization’s normal stock and comparing warrants to buy 714,780 shares of the organization’s basic stock. The normal stock and comparing warrants will be sold in mix, with one warrant to buy 0.20 of an offer of regular stock for every offer of basic stock sold. The joined price tag for every offer of basic stock and comparing warrant is $1.95.
Identiv, Inc. (INVE), a worldwide security innovation organization that gives trusted character answers for premises, data, and regular things, today reported it will report monetary results for the final quarter and financial year finished December 31, 2014 on Thursday, March 12, 2015 after close of business sector. Identiv will have a telephone call and sound webcast to talk about the outcomes at 2:00 PM PT (5:00 PM ET).
After the endorsing markdown and assessed offering costs payable by the Transgenomic, Transgenomic hopes to get net returns of pretty nearly $6.2 million. The offering is required to close approximately March 4, 2015, subject to standard shutting conditions.
Transgenomic Inc (NASDAQ:TBIO) dropped -21.27% at $1.74 & Identiv Inc (NASDAQ:INVE) dove -6.48% at $9.67 both were moving down.
Identiv is a worldwide security innovation organization that builds character in the associated world, including premises, data, and ordinary things & Transgenomic, Inc. works as a biotechnology organization that centers progressing customized pharmaceutical in the recognition and treatment of disease and acquired maladies through its restrictive sub-atomic advancements and clinical and examination benefits in the United States, Italy, the United Kingdom, Germany, France, and globally.
